Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proton Therapy for Mediastinal Lymphoma (PROMLY)

NCT07817641 is registered in ClinicalTrials.gov with Copenhagen University Hospital, Rigshospitalet as lead sponsor.

NCT NCT07817641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07817641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proton Therapy for Mediastinal Lymphoma (PROMLY)
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2026
Completion date
May 1, 2046
Enrollment
139 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma (dlbcl), hodgkin disease lymphoma, mediastinal lymphoma